Characterization of Entamoeba histolytica adenosine 5'-phosphosulfate (APS) kinase; validation as a target and provision of leads for the development of new drugs against amoebiasis.
<h4>Background</h4>Amoebiasis, caused by Entamoeba histolytica infection, is a global public health problem. However, available drugs to treat amoebiasis are currently limited, and no effective vaccine exists. Therefore, development of new preventive measures against amoebiasis is urgent...
Main Authors: | Fumika Mi-Ichi, Takeshi Ishikawa, Vo Kha Tam, Sharmina Deloer, Shinjiro Hamano, Tsuyoshi Hamada, Hiroki Yoshida |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2019-08-01
|
Series: | PLoS Neglected Tropical Diseases |
Online Access: | https://doi.org/10.1371/journal.pntd.0007633 |
Similar Items
-
3D-QSAR study of adenosine 5’-phosphosulfate (APS) analouges as ligands for APS reductase
by: Erić Slavica, et al.
Published: (2021-01-01) -
Entamoeba Encystation: New Targets to Prevent the Transmission of Amebiasis.
by: Fumika Mi-Ichi, et al.
Published: (2016-10-01) -
A Flow Cytometry Method for Dissecting the Cell Differentiation Process of Entamoeba Encystation
by: Fumika Mi-ichi, et al.
Published: (2018-07-01) -
Species-specific immunity induced by infection with Entamoeba histolytica and Entamoeba moshkovskii in mice.
by: Chikako Shimokawa, et al.
Published: (2013-01-01) -
Correction: Species-Specific Immunity Induced by Infection with Entamoeba histolytica and Entamoeba moshkovskii in Mice
by: Chikako Shimokawa, et al.
Published: (2013-01-01)